Pediatric Brain Tumor
33
8
11
9
Key Insights
Highlights
Success Rate
69% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
12.1%
4 terminated out of 33 trials
69.2%
-17.3% vs benchmark
0%
0 trials in Phase 3/4
22%
2 of 9 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 9 completed trials
Clinical Trials (33)
Effectiveness of a Visual Telerehabilitation Program on Visual Perception in Children, Adolescents and Young Adults With Hemianopsia Consecutive to a Brain Tumour
Intra-Tumoral Injections of Natural Killer Cells for Recurrent Malignant Pediatric Brain Tumors
HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
Targeting Pediatric Brain Tumors and Relapsed/Refractory Solid Tumors With Sodium Glucose Cotransporter 2 Inhibitors (SGLT2i)
Dose Escalation Study of CLR 131 in Pediatric Relapsed/Refractory Malignant Tumors Including Neuroblastoma and Sarcomas
High-Intensity Interval Exercise in Young Adult Survivors of Pediatric Brain Tumors: A Pilot Feasibility Study
GPC2-CAR T Cell Therapy for Relapsed or Refractory Medulloblastoma in Children and Young Adults
A Multicenter Study to Assess the Feasibility of 5-Aminolevulinic Acid (5-ALA) in Pediatric Brain Tumor Patients
Survivors Journey+
Understanding the Late Effects of Surviving a Pediatric Brain Tumor
A Study of Ad-RTS-hIL-12 + Veledimex in Pediatric Subjects With Brain Tumors Including DIPG
Effect of Hydrotherapy on Children With Brain Tumor
9-ING-41 in Pediatric Patients With Refractory Malignancies.
Fitness to Aid the Brain and Cognitive Skills
Clinical Benefit of Using Molecular Profiling to Determine an Individualized Treatment Plan for Patients With High Grade Glioma
Evaluation of the Neurologic Assessment in Pediatric Neuro-Oncology (pNANO)
Non-Helium Magnetoencephalography in Pediatric Brain Tumors
The FLaME Cognitive Rehabilitation Study for Childhood Brain Tumour
Feasibility/Acceptability of Attentional-Control Training in Survivors
SJDAWN: St. Jude Children's Research Hospital Phase 1 Study Evaluating Molecularly-Driven Doublet Therapies for Children and Young Adults With Recurrent Brain Tumors